Table 1 Experimental design, animal model construction.

From: Modulatory effect of quercetin on premature ovarian insufficiency induced by cyclophosphamide via the PARP1 and GSK3β

Group

Mode of modeling and administration

Control group

Normal rats were injected with an equal volume of normal saline intraperitoneally

POI group

CTX was injected intraperitoneally at a dose of 200 mg/kg initially, and then continuously at a dose of 8 mg/kg for 15 days

QR group

Starting from the modeling day, 100 mg/kg/d QR was orally administered for 30 days

QR + POI group

Starting from the modeling day, 100 mg/kg/d QR was orally administered for 30 days

EV + POI group

20 mg/kg/d estradiol valerate was given by gavage for 30 days from the day of modeling

  1. Note: The dosage of QR, CTX, and estradiol valerate was selected according to the previous data38,39,40,41.